Shining a Light on Drug Development: Revolutionizing Radiolabeling

Article   Nov 09, 2017 | by Laura Elizabeth Mason, Science Editor, Technology Networks

 
Shining a Light on Drug Development: Revolutionizing Radiolabeling

A blue LED shines on a vial containing heavy water, a pharmaceutical compound, and a light-activated catalyst. The new photocatalytic approach from Princeton's David MacMillan turns a multi-month process into a one-day step, speeding the arrival of new drugs to the marketplace. Credit: David MacMillan/Princeton University

Laura Mason

Science Writer

 
 
 

RELATED ARTICLES

A Hangover Pill? Tests on drunk mice show promise

Article

Scientists create capsules filled with natural enzymes usually found in liver cells to help the body process the alcohol faster.

READ MORE

Will Microfluidic Cell Culture Fulfill its Long-awaited Potential?

Article

The first paper ever published on microfluidic cell culture is 19 years old. Microfluidic cell culture has now outgrown its infancy and is about to survive its teenage years. It has matured considerably but still needs to transition from academia into clinics and industry. Will it come of age?

READ MORE

The 3D Structure of Telomerase: Uncovering Its Role in Human Disease

Article

Researchers have published the first detailed picture and description of the 3-dimensional molecular structure of telomerase – a discovery that could enable better targeted drug screening and could result in more successful telomerase-related clinical therapeutics.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE